Our thorough investigation concludes by demonstrating the crucial function of IGFBP7 in controlling the immunological milieu surrounding tumours and lactic acid metabolism, eventually leading to immunotherapy resistance in STAD. The gene discussed is IGFBP7; the disease is neoplasm.